Several studies have highlighted the involvement of microtubule-associated proteins (MAPs) in brain cancer biology, suggesting their potential as novel therapeutic targets for treating glioma (Breuzard et al. 2019; Verissimo et al. 2010; Wattanathamsan and Pongrakhananon 2022). This evidence concerns the gene C3orf62 and glioma.